Resistance Patterns in Gram-Negative Bacilli Isolated in a Secondary Care Hospital: A Therapeutic Challenge in Western Mexico

Read full text
Authors: César Ricardo Cortez-Álvarez, Benjamín de Jesús Gutiérrez-García, Pablo Ulises Romero-Mendoza, María del Rosario Cabral-Medina, Monserratt Abud-Gonzalez, Susana Olivia Guerra-Martínez, Livier Amalia Gutierrez-Morales, María Luisa Muñoz Almaguer, Santiago José Guevara-Martínez, Daniel Osmar Suárez-Rico, Marco Pérez-Cisneros, Martín Zermeño-Ruiz
Cited by: 0
References: 25

Abstract

Antimicrobial resistance (AMR) continues to represent a significant global public health concern. Gram-negative bacilli (GNB) are the primary causative agents of severe nosocomial infections and possess a notable capacity to develop resistance mechanisms that restrict therapeutic options. The objective of this study was to characterize the antimicrobial susceptibility profiles of GNB isolated at a secondary-level hospital in Guadalajara, Mexico, with the aim of identifying predominant resistance patterns and the most effective therapeutic alternatives. A descriptive, retrospective, cross-sectional study was conducted using clinical isolates of Acinetobacter spp., Pseudomonas spp., Escherichia coli, Klebsiella spp., Morganella morganii, Proteus spp., and Enterobacter spp. collected during 2024. The identification and susceptibility testing were carried out using the VITEK® 2 automated system, and the results were interpreted in accordance with CLSI guidelines. High resistance rates were observed in Acinetobacter spp. and Pseudomonas spp., particularly to carbapenems (>50% and >40%, respectively). Escherichia coli and Klebsiella spp. demonstrated resistance to third-generation cephalosporins and trimethoprim/sulfamethoxazole, exhibiting high susceptibility to amikacin and carbapenems (>90%). New-generation β-lactam/β-lactamase inhibitor combinations, such as ceftazidime/avibactam and ceftolozane/tazobactam, have demonstrated high efficacy against resistant strains. Overall, GNB isolates in this secondary-level hospital demonstrated elevated resistance levels, particularly to β-lactams and carbapenems, which pose a significant therapeutic challenge. Nevertheless, amikacin, carbapenems, and new-generation β-lactams persist as valuable therapeutic options. In order to contain the spread of multidrug-resistant organisms, it is imperative to strengthen local surveillance, optimize antibiotic stewardship, and reinforce infection control measures.

Fields of Study & Subjects

Antibiotic Resistance in Bacteria Antibiotic Use and Resistance Infections and bacterial resistance

Publication details

Journal / source
Microbiology Research
Volume
17
Issue
1
Pages
17–17
Publication date
10 January 2026
Language
EN